BamSEC and AlphaSense Join Forces
Learn More

Concert Pharmaceuticals Inc

Formerly NASDAQ: CNCE

Material Contracts Filter

EX-10.18
from 10-K 42 pages Royalty Purchase Agreement
12/34/56
EX-10.12
from 10-K 2 pages Summary of Non-Employee Director Compensation Program
12/34/56
EX-10.1
from 8-K 43 pages Securities Purchase Agreement
12/34/56
EX-10.1
from 8-K 4 pages Material contract
12/34/56
EX-10.12
from 10-K 2 pages Summary of Non-Employee Director Compensation Program
12/34/56
EX-10.12
from 10-K ~1 page Summary of Non-Employee Director Compensation Program
12/34/56
EX-10.9
from 10-K 7 pages [Name and Address] Dear [Name]
12/34/56
EX-10.8
from 10-K 9 pages This Agreement Revises the Terms of Your Continued Employment as President and Chief Executive Officer of Concert Pharmaceuticals, Inc. (The “Company” or “Concert” And, With You, the “Parties”) Reporting Directly to the Company’s Board of Directors (The “Board”), Effective as of [_], 2018 (The “Effective Date”). You Agree to Continue to Perform the Duties of Your Position and Such Other Duties as the Board May Reasonably Assign to You From Time to Time
12/34/56
EX-10.22
from 10-K ~1 page Summary of Director Compensation Program
12/34/56
EX-10.22
from 10-K ~1 page Summary of Director Compensation Program
12/34/56
EX-10.10
from 10-K 121 pages 65 Hayden Avenue Lexington, Massachusetts Lease Summary Sheet
12/34/56
EX-10.9
from 10-K ~10 pages Form of Employment Agreement [Date]
12/34/56
EX-10.1
from 8-K 2 pages Concert Pharmaceuticals, Inc. Restricted Stock Unit Award Agreement Granted Under 2014 Stock Incentive Plan
12/34/56
EX-10.1
from 8-K 48 pages Material contract
12/34/56
EX-10.22
from 10-K ~1 page Summary of Director Compensation Program
12/34/56
EX-10.12
from 10-K 70 pages Material contract
12/34/56
EX-10.11
from 10-K ~1 page Via Hand Delivery March 1, 2017 Ian Robert Silverman C/O Concert Pharmaceuticals, Inc. 99 Hayden Avenue, Suite 500 Lexington, Ma 02421 Dear Bob
12/34/56
EX-10.10
from 10-K 6 pages Form of Employment Agreement
12/34/56
EX-10.21
from 10-K 1 page Summary of Director Compensation Program
12/34/56
EX-10.2
from 10-Q 23 pages Patent Assignment Agreement
12/34/56